DANIEL SCHLOEGEL: Open Payments
NPI 1184189250 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 10 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $1,116 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $68 |
| UROGEN PHARMA, INC. | 1 | $60 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| DJO, LLC | 1 | $21 |
| TOLMAR, INC. | 1 | $20 |
| Teleflex LLC | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: GEMTESA, ADSTILADRIN, CMF, ELIGARD, BARRIGEL, ORGOVYX, ERLEADA.
Industry payments across FL — which companies pay providers there.
